We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.92B
AUM Growth
-$382M
Cap. Flow
-$115M
Cap. Flow %
-5.98%
Top 10 Hldgs %
45.28%
Holding
275
New
41
Increased
31
Reduced
101
Closed
38

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$24.8M
2
ASTH icon
Astrana Health
ASTH
+$16.6M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$15.8M
4
LLY icon
Eli Lilly
LLY
+$15.2M
5
GPC icon
Genuine Parts
GPC
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 23.91%
2 Consumer Discretionary 7.8%
3 Financials 6.79%
4 Industrials 3.72%
5 Materials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRLSW icon
226
Borealis Foods Inc Warrant
BRLSW
$15.5K ﹤0.01%
200,000
EVAC.WS
227
EQV Ventures Acquisition Corp II Warrants
EVAC.WS
$15K ﹤0.01%
50,000
LWACW
228
LightWave Acquisition Corp Warrants
LWACW
$2.37M
$12K ﹤0.01%
50,000
OYSER
229
Oyster Enterprises II Acquisition Corp Rights
OYSER
$9.38K ﹤0.01%
75,000
ECXWW
230
ECARX Holdings Warrants
ECXWW
$6.5K ﹤0.01%
125,000
MSAIW icon
231
MultiSensor AI Holdings Warrant
MSAIW
$949K
$5.87K ﹤0.01%
150,000
ORIQW
232
Origin Investment Corp I Warrant
ORIQW
$18.4K
$2.02K ﹤0.01%
15,000
APLMW icon
233
Apollomics Inc Warrant
APLMW
$1.7M
$1.98K ﹤0.01%
130,000
AKA icon
234
a.k.a. Brands
AKA
$119M
-36,417
Closed -$390K
ANIX icon
235
Anixa Biosciences
ANIX
$126M
-113,636
Closed -$355K
ARCT icon
236
PUT
Arcturus Therapeutics
ARCT
$157M
-24,000
Closed -$147K
BBIO icon
237
BridgeBio Pharma
BBIO
$16.5B
-2,000
Closed -$153K
BTCS icon
238
BTCS Inc
BTCS
$49.3M
-161,992
Closed -$428K
COF icon
239
PUT
Capital One
COF
$124B
-75,000
Closed -$18.2M
COIN icon
240
Coinbase
COIN
$41.7B
-15,700
Closed -$3.09M
CRGO icon
241
Freightos
CRGO
$65.1M
-143,269
Closed -$327K
DTIL icon
242
Precision BioSciences
DTIL
$188M
-97,085
Closed -$404K
GOSS icon
243
CALL
Gossamer Bio
GOSS
$66.5M
-300,100
Closed -$930K
GPMT
244
Granite Point Mortgage Trust
GPMT
$63.7M
-183,150
Closed -$440K
HCC icon
245
Warrior Met Coal
HCC
$4.23B
-10,000
Closed -$882K
HRMY icon
246
Harmony Biosciences
HRMY
$2.04B
-415,000
Closed -$13.6M
KVUE icon
247
PUT
Kenvue
KVUE
$37B
-100,000
Closed -$1.73M
MBC icon
248
MasterBrand
MBC
$1.09B
-200,000
Closed -$2.21M
MCRB icon
249
Seres Therapeutics
MCRB
$48M
-52,314
Closed -$778K
MEDP icon
250
PUT
Medpace
MEDP
$16.8B
-20,000
Closed -$11.2M

Similar funds

683 Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, 683 Capital Management held 275 positions worth $1.92B, down 17% from $2.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

683 Capital Management withdrew a net $115M in Q1 2026, closing 38 positions and reducing 101 holdings. Its most notable exit was UWM Holdings, an estimated $30.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Astrana Health worth $17.2M.

  • 683 Capital Management's largest Q1 2026 buy was Astrana Health: 700,000 shares worth $17.2M.
  • 683 Capital Management added most to Becton Dickinson in Q1 2026, an estimated $24.8M increase.
  • 683 Capital Management's biggest Q1 2026 reduction was GXO Logistics, cutting an estimated $10.6M.
  • 683 Capital Management fully exited UWM Holdings in Q1 2026, selling an estimated $30.9M.
  • 683 Capital Management's ten largest holdings make up 45% of its $1.92B portfolio in Q1 2026.
  • 683 Capital Management opened 41 new positions and closed 38 in Q1 2026.
  • 683 Capital Management's portfolio value fell 17% quarter-over-quarter to $1.92B.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.